Daily News Podcast

Polysomnography beats Fitbit


 

Fitbit and sleep applications for smartphones should not be recommended as screening tools for obstructive sleep apnea. Also today, there is no evidence for the disease-modifying effect of levodopa in Parkinson’s Disease, and ablation surpassed drugs for raising quality of life for atrial fibrillation.

Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

Recommended Reading

Prescribed opioids and pneumonia risk
MDedge Neurology
SNOT-22 may help identify patients with undiagnosed OSA
MDedge Neurology
Meta-analysis supports aspirin to reduce cardiovascular events
MDedge Neurology
Survey: Americans support Medicare for all
MDedge Neurology
Age of migraine onset may affect stroke risk
MDedge Neurology
Useful financial and efficiency advice to practices is hard to come by
MDedge Neurology
DBS provides long-term benefits for patients with Parkinson’s disease
MDedge Neurology
Drug-pricing policies find new momentum as ‘a 2020 thing’
MDedge Neurology
Diagnosing OSA: Polysomnography beats Fitbit, apps
MDedge Neurology
Before you refer for AF ablation
MDedge Neurology